# DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

> **NCT00387829** · NA · TERMINATED · sponsor: **Integra LifeSciences Corporation** · enrollment: 347 (actual)

## Conditions studied

- Spinal Injuries
- Adhesions

## Interventions

- **DEVICE:** DuraGen Plus Adhesion Barrier Matrix

## Key facts

- **NCT ID:** NCT00387829
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 347 (ACTUAL)
- **Why stopped:** Sponsor voluntarily terminated study
- **Last updated:** 2017-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387829, "DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00387829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*